Interestingly, recent studies have confirmed that c-Myc functions as a transcriptional activator of SOX2 by binding to SOX2 gene promoter, and cooperates with SOX2 to maintain stemness and tumorigenicity in breast and lung cancer [32]. This evidence concerns the gene MYC and lung cancer.